Major pharmaceutical companies, small and medium-sized enterprises (SMEs) and academia join forces in an IMI-supported Public Private Partnership (PPP) to accelerate early drug discovery and so address the ever-increasing need for innovative therapeutics to tackle unmet medical needs
The European Lead Factory, a novel platform for innovative drug discovery, was launched today by an international consortium of 30 partners. This partnership, the first of its kind, is supported by the Innovative Medicines Initiative (IMI) and creates unprecedented opportunities for the discovery of new medicines by providing public partners with an ‘industry-like’ discovery platform to translate cutting-edge academic research into high-quality drug lead molecules on a scale and speed that was not possible previously...
Read MoreHORIBA Medical UK incorporated into HORIBA UK Ltd - enhancing expertise sharingFeb 22, 2013
Organisational change brings UK’s HORIBA Group companies together
HORIBA UK Ltd, Medical division – today announces that from 1st January 2013 the UK’s HORIBA Group companies have been brought together into one company to establish HORIBA UK Ltd. Through this organisational change, the UK’s HORIBA Group business segments can streamline operational activities and enhance on-going product research and development...
Read MoreFDA to Discuss Food Safety Modernization Act (FSMA) at Food Labs Conference in Conjunction with Pittcon 2013Feb 19, 2013
Food Safety Tech, the organizers of Food Labs Conference, which will be held in conjunction with Pittcon 2013, March 19-20, at the Pennsylvania Convention Center, Philadelphia, PA, announces the agenda of speakers for the two-day event
The Food Labs program will open with a presentation by Palmer A. Orlandi, Ph.D. CAPT, U.S. Public Health Service, Sr. Science Advisor Office of Foods and Veterinary Medicine, U.S. Food & Drug Administration on the Food Safety Modernization Act (FSMA) and the regulation's impact on food laboratories. According to information from the FDA website, FSMA is the most sweeping reform of FDA's food safety authority in more than 70 years...
Read MoreCarl Zeiss Receives Second Prize at 2013 CLEAN! Fraunhofer Cleanliness Technology AwardFeb 19, 2013
Jury Impressed by Correlative Particle Analysis
On 6 February 2013, the Microscopy business group of Carl Zeiss received second prize in the 2013 CLEAN! Fraunhofer Cleanliness Technology Award for its Correlative Particle Analyzer (CAPA). The judges of the Fraunhofer Institute for Production Technology and Automation (IPA) honored the three award winners on day two of the Cleanroom Lounge trade fair in Karlsruhe. "By bridging scanning electron and light microscopy, Correlative Particle Analyzer is revolutionizing cleanliness technology," said the Fraunhofer Institute commenting on its success....
Read MoreResponse to the 2013 State of the Union AddressFeb 18, 2013
“The American Chemical Society (ACS) thanks President Barack Obama and congressional leaders who have prioritized creating jobs for Americans as the most critical challenge during these difficult economic times”
“As the world’s largest scientific society with over 163,000 members — chemists, chemical engineers, biomedical chemists, other allied science professionals, teachers, entrepreneurs and leaders in industry, academia, government and small business — we wholeheartedly agree with the importance of this issue as outlined in the President’s State of the Union address and remarks by leaders from both parties in Congress.”...Read MoreMetrohm and FOSS enter strategic allianceFeb 15, 2013
Metrohm and FOSS have entered into a strategic alliance strengthening the two companies’ leading positions in their respective key markets. In this strategic alliance, Metrohm will become the sole global distributor of FOSS NIR instruments for the chemical, petrochemical, pharmaceutical, and environmental sectors
“Metrohm will extend its product offering beyond the company’s traditional focus on solutions for wet-chemistry analytical techniques thereby benefiting our customers with new possibilities both in laboratory and process analysis”, said Dr. Christoph Fässler, CEO of Metrohm....
Frost & Sullivan will present global trends, challenges and opportunities with a focus on Europe at the 2nd Biosimilars Congregation in London this month
Top representatives from the healthcare industry are confirmed to attend the 2nd Biosimilars Congregation which will take place in London on the 19th and 20th of February 2013. Ranjith Gopinathan, Frost & Sullivan Program Manager for Life Sciences, Europe Practice is set to participate to the event’s Keynote Panel Discussion focusing on challenges and opportunities in the global biosimilars market....
Read MoreLIMS on show at ArabLab 2013Feb 15, 2013
Autoscribe will be demonstrating the flexibility and scalability offered by its flagship Matrix Gemini LIMS (Laboratory Information Management System) at the ArabLab exhibition. Autoscribe will be exhibiting on the booth of its local distributor, Laboratory Automation Services Middle East FX-LLC
Matrix Gemini has applications in a wide range of laboratories including, food, pharmaceutical, chemicals, oil, petrochemicals, veterinary, healthcare, and environmental information management systems. In addition, Matrix Gemini’s Quality Management Suite provides a comprehensive business data management capability and facilitates compliance with ISO 9001 (2008) and ISO/TS 16949 (2002)....
Read MoreVeeva Systems Introduces Regulatory Compliant Email Solution for Global Life Sciences CompaniesFeb 15, 2013
New cloud solution empowers pharmaceutical sales teams with integrated email to maximize productivity
Veeva Systems’ new Approved Email solution is set to radically increase the productivity of life sciences sales teams by enabling users to email approved content to customers directly from iRep and Veeva CRM. Veeva CRM Approved Email represents a technology and business breakthrough in the industry as the first end-to-end solution to enable regulatory compliant email communication between sales reps and healthcare practitioners...
Read More1st Metrohm Environmental Analysis Symposium, November 19th Feb 14, 2013
Metrohm is pleased to invite professionals from academic research, public authorities, and the private sector to the 1st Metrohm Environmental Analysis Symposium
Join us in this 3-day event and catch up with the latest analytical methods during presentations and practical demonstrations. Discuss challenges in environmental analysis with experts and colleagues from all over the world and enjoy three days of inspiring learning in the beautiful Appenzellerland. Participants will get to know the latest analytical solutions developed by Metrohm for environmental analysis and can test them in practice. There will be plenty of opportunities to exchange ideas and discuss questions with Metrohm’s application chemists as well as peers from research and various industries. Guest speakers include specialists from environmental laboratories, authorities, standards organizations, and academia...
Microfluidics expert Dolomite has reported an exceptional 20% year-on-year growth in 2012
Thanks to the launch of a number of novel microfluidic products including the Porous Media Chip specially designed for petrochemical research, a range of compact Electro-Osmotic Pumps for easy integration into microfluidic systems as well as an innovative Closed-Loop Flow Control System which can be used together with Dolomite’s Mitos P-Pump for better control of micro-scale flow rates
Malvern Instruments’ new series of web-based Imaging Masterclasses kicks off on 26 February 2013 with an introduction to imaging for particle characterization
The series will then continue through the year and will cover a broad range of imaging topics. Alongside this will run the laser diffraction Masterclass series which will discuss subjects including wet method development, dry method development, optical property selection and specification setting...
Autoscribe has invited a number of biobanking experts to share their views and experiences on how to meet compliance regulations yet retain the flexibility to meet individual application requirements at three seminars to be held in the UK
These free, full-day seminars will be held in London on 7th March, Manchester on 12th March and Edinburgh on 23rd April. These seminars will be of particular interest to anyone involved in biobanks in biotechnology, pharmaceutical and medical research...
Read MoreBioCity Scotland announced as UK hub for major European drug discovery projectFeb 7, 2013
Scottish First Minister Rt. Hon Alex Salmond MSP has welcomed today’s news that a major new pharmaceutical drug discovery initiative is to be centred at BioCity Scotland in Lanarkshire, in partnership with the University of Dundee
The project will bring at least €19 million (£16.3 million) of research funding to Scotland following today’s announcement by the Innovative Medicines Initiative (IMI) of the launch of the European Lead Factory.Accelerating the development of a new generation of drugs is behind the announcement by an international consortium of 30 partners taking part in the European Lead Factory, a novel platform for innovative drug discovery...
Read MoreCarl Zeiss Research Award Goes to Professor Anne L'HuillierFeb 7, 2013
Swedish-French scientist in the field of attosecond physics honored
The winner of this year's Carl Zeiss Research Award, one of the most renowned honors in optics, goes to Professor Anne L’Huillier from Lund University in Sweden. L’Huillier is being honored for her pioneering work in the field of high harmonic generation which has laid the foundation for the generation of attosecond impulses and enabled key advances in attosecond physics."Professor L’Huillier not only described the theory of attosecond technology, but also verified it experimentally”, stated the jury in announcing its decision. Her works enables further development and application of this technology...
Despite challenging economic conditions and in the face of fierce competition, Shimadzu UK has achieved sales order growth of 30% in the last two years
This growth has been achieved across many products in the formidable Shimadzu range including GC, GCMS, LC, LCMS, Spectroscopy, TOC and Material Testing Solutions. A long-established company, Shimadzu is a global presence in mass spectrometry, chromatography, atomic spectroscopy and thermal analysis, and is known for its high quality engineering and robust, technically advanced scientific instrumentation...
EMA and FDA recommend mRNA testing in ADME-Tox studies for superior sensitivity
Plexpress, developer of the innovative TRAC (Transcript Analysis with the aid of Affinity Capture) platform for high-throughput gene expression analysis,has announced dedicated ADME-Tox programs for contract research organizations (CROs). This follows FDA draft guidance suggesting measurement of CYP mRNA levels for ADME-Tox studies, and EMA final guidelines stating that mRNA analysis should be used in drug interaction studies in order to increase the sensitivity of assays...
With the introduction of the Morphologi G3-ID system last year, Malvern Instruments is providing researchers with the ability to apply morphologically directed Raman spectroscopy to a range of different sample types
Such advanced particle analysis is proving valuable and highly effective in applications that include inhaled product characterization and pharmaceutical bioequivalence studies, bioequivalence for nasal sprays being referenced specifically in a talk given by the FDA at this year’s IFPAC conference [January 22-25, 2013 Baltimore, MD, USA]. The use of morphologically targeted Raman spectroscopy has also been described in an independent article, as part of granulation studies, to provide the physical and chemical identities of particles in mixed populations [1]...
Read MoreContract Research Organisations offer Promise of Innovative, Safe and Effective Drug Development, Says Frost & SullivanFeb 5, 2013
Ability to provide complete and cost-effective solutions for pharma and biotechnology firms drives uptake of CRO services
Pharmaceutical and biotech companies are outsourcing research in order to develop innovative products that meet the rising demand for therapeutics across a range of diseases. The willingness of contract research organisations (CROs) to invest in state-of-the-art facilities to conduct clinical trials is further advancing market prospects. New analysis from Frost & Sullivan, Analysis of the European Contract Research Outsourcing Markets, finds that the markets earned revenues of approximately $6.07 billion in 2011 and estimates this to reach $11.54 billion in 2018...
Read MoresparkV10 Chosen to Facilitate the Hit Optimization Process in ProMining TherapeuticsFeb 5, 2013
Cresset Group, innovative provider of chemistry software and services, announces that ProMining Therapeutics Ltd has chosen to license sparkV10 for assistance in its hit-to-lead optimization efforts
sparkV10 is Cresset’s desktop bioisostere software tool which is used by medicinal and computational chemists for drug design. sparkV10 is an exciting and powerful way of generating novel and diverse structures. We are delighted that ProMining, an early-stage biopharmaceutical research and development company, has chosen to work with sparkV10 for the development of small molecule drugs,” says Dr David Bardsley, Cresset’s Sales Director...
Read MoreProvence Technologies launches new USD 1.7 million (EUR 1.3 million) research programme Feb 4, 2013
Screening 1000, the research project conducted by Provence Technologies, is set up to find and market a new ultra-pure molecule
Provence Technologies, a research laboratory specialising in fine chemistry, announces today the launch of Screening 1000, a new USD 1.7 million (EUR 1.3 million) research programme with the goal of discovering a new ultra-pure molecule for the healthcare market. The project is being launched by the R&D department of Provence Technologies and is being co-financed equally by Oseo, the French innovation promotion agency and Provence Technologies. The programme is planned to run for two years and aims to develop a new range of products...
Read MoreThe Photonex London Roadshow showcases photonic techniques, tools and equipment at University College London on the 9th April Feb 4, 2013
Arrangements for the 2013 annual Photonex London Roadshow are well under way to include a conference, photonics tutorials and an exhibition of 25 companies
Following on from the success of the inaugural event, Xmark Media is organising the second Photonics Technology Roadshow at University College London. Once more, visitors will be able to attend a free conference and visit an exhibition from 25 leading suppliers of photonics technologies. Continuing the goal to visit a different London university each year, UCL is this year's host and is embracing the opportunity by becoming fully involved with the event planning to make it a success for all attendees...
Read More